Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

New Research Coverage Highlights Durect, Credit Suisse Group, Obsidian Energy, TransCanada, Golden Star Resources, and Loxo Oncology — Consolidated Revenues, Company Growth, and Expectations for 2018

DRRX, T.OBE, T.TRP

NEW YORK, June 07, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Durect Corporation (NASDAQ:DRRX), Credit Suisse Group (NYSE:CS), Obsidian Energy (NYSE:OBE), TransCanada Corporation (NYSE:TRP), Golden Star Resources, Ltd (NYSE:GSS), and Loxo Oncology, Inc. (NASDAQ:LOXO), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

DRRX DOWNLOAD: http://Fundamental-Markets.com/register/?so=DRRX
CS DOWNLOAD: http://Fundamental-Markets.com/register/?so=CS
OBE DOWNLOAD: http://Fundamental-Markets.com/register/?so=OBE
TRP DOWNLOAD: http://Fundamental-Markets.com/register/?so=TRP
GSS DOWNLOAD: http://Fundamental-Markets.com/register/?so=GSS
LOXO DOWNLOAD: http://Fundamental-Markets.com/register/?so=LOXO

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Durect Corporation (NASDAQ:DRRX), Credit Suisse Group (NYSE:CS), Obsidian Energy (NYSE:OBE), TransCanada Corporation (NYSE:TRP), Golden Star Resources, Ltd (NYSE:GSS), and Loxo Oncology, Inc. (NASDAQ:LOXO) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed June 4th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

DURECT CORPORATION (DRRX) REPORT OVERVIEW

Durect's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Durect reported revenue of $3.49MM vs $4.57MM (down 23.63%) and basic earnings per share -$0.05 vs -$0.06. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Durect reported revenue of $49.17MM vs $14.03MM (up 250.59%) and basic earnings per share -$0.03 vs -$0.26. Durect is expected to report earnings on August 14th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.07. The estimated EPS forecast for the next fiscal year is -$0.24 and is expected to report on March 7th, 2019.

To read the full Durect Corporation (DRRX) report, download it here: http://Fundamental-Markets.com/register/?so=DRRX

-----------------------------------------

CREDIT SUISSE GROUP (CS) REPORT OVERVIEW

Credit Suisse Group's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Credit Suisse Group reported interest income of $4,696.25MM vs $4,026.64MM (up 16.63%) and basic earnings per share $0.28 vs $0.28 (up 2.11%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Credit Suisse Group reported interest income of $17,335.03MM vs $17,639.82MM (down 1.73%) and basic earnings per share -$0.42 vs -$1.34. Credit Suisse Group is expected to report earnings on July 27th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.13. The estimated EPS forecast for the next fiscal year is $1.88 and is expected to report on February 13th, 2019.

To read the full Credit Suisse Group (CS) report, download it here: http://Fundamental-Markets.com/register/?so=CS

-----------------------------------------

OBSIDIAN ENERGY (OBE) REPORT OVERVIEW

Obsidian Energy's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Obsidian Energy reported revenue of $91.78MM vs $91.43MM (up 0.38%) and basic earnings per share -$0.10 vs $0.04. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Obsidian Energy reported revenue of $337.10MM vs $459.16MM (down 26.58%) and basic earnings per share -$0.13 vs -$1.05. Obsidian Energy is expected to report earnings on August 8th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.01. The estimated EPS forecast for the next fiscal year is -$0.09 and is expected to report on March 6th, 2019.

To read the full Obsidian Energy (OBE) report, download it here: http://Fundamental-Markets.com/register/?so=OBE

-----------------------------------------

TRANSCANADA CORPORATION (TRP) REPORT OVERVIEW

TransCanada's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, TransCanada reported revenue of $2,709.07MM vs $2,562.24MM (up 5.73%) and basic earnings per share $0.66 vs $0.56 (up 17.48%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, TransCanada reported revenue of $10,374.56MM vs $9,443.78MM (up 9.86%) and basic earnings per share $2.65 vs $0.12 (up 2,093.06%). TransCanada is expected to report earnings on July 27th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.56. The estimated EPS forecast for the next fiscal year is $2.76 and is expected to report on February 21st, 2019.

To read the full TransCanada Corporation (TRP) report, download it here: http://Fundamental-Markets.com/register/?so=TRP

-----------------------------------------

GOLDEN STAR RESOURCES, LTD (GSS) REPORT OVERVIEW

Golden Star Resources' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Golden Star Resources reported revenue of $70.82MM vs $68.55MM (up 3.32%) and basic earnings per share $0.00 vs $0.00. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Golden Star Resources reported revenue of $315.50MM vs $221.29MM (up 42.57%) and basic earnings per share $0.10 vs -$0.13. Golden Star Resources is expected to report earnings on August 7th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.02. The estimated EPS forecast for the next fiscal year is $0.20 and is expected to report on February 19th, 2019.

To read the full Golden Star Resources, Ltd (GSS) report, download it here: http://Fundamental-Markets.com/register/?so=GSS

-----------------------------------------

LOXO ONCOLOGY, INC. (LOXO) REPORT OVERVIEW

Loxo Oncology's Recent Financial Performance

Loxo Oncology is expected to report earnings on August 14th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$1.14. The estimated EPS forecast for the next fiscal year is -$1.91 and is expected to report on March 7th, 2019.

To read the full Loxo Oncology, Inc. (LOXO) report, download it here: http://Fundamental-Markets.com/register/?so=LOXO

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Primary Logo



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today